FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161425022> ?p ?o ?g. }

• W2161425022 endingPage "1519" @default.
• W2161425022 startingPage "1508" @default.
• W2161425022 abstract "Abstract Current combination therapies for advanced breast cancer provide a modest survival benefit but with greater toxicity than with monotherapies. New combinations are needed that improve the efficacy of current treatments and have acceptable tolerability profiles. Recent clinical trials have assessed the efficacy and safety of the multikinase inhibitor sorafenib in combination with common treatments for advanced breast cancer. Sorafenib has both antiangiogenic and antiproliferative activities and is indicated for patients with unresectable hepatocellular and advanced renal cell carcinoma. Generally, sorafenib is associated with manageable, non–life-threatening adverse events. One of the more common adverse events seen with sorafenib is hand–foot skin reaction, a dermatologic toxicity usually localized to the pressure points of the palms and soles. Although hand–foot skin reaction is reversible and not life threatening, it can have a significant impact on a patient's quality of life and may necessitate dose modification. Moreover, sorafenib is being evaluated in combination with breast cancer treatments that are associated with a similar dermatologic toxicity (e.g., capecitabine-induced hand–foot syndrome). This review looks at the use of sorafenib in combination with selected chemotherapies in patients with advanced breast cancer and considers the incidence, prevention, and management of hand–foot skin reaction." @default.
• W2161425022 created "2016-06-24" @default.
• W2161425022 creator A5015349477 @default.
• W2161425022 creator A5073714778 @default.
• W2161425022 date "2011-10-20" @default.
• W2161425022 modified "2023-09-26" @default.
• W2161425022 title "Clinical Presentation and Management of Hand–Foot Skin Reaction Associated with Sorafenib in Combination with Cytotoxic Chemotherapy: Experience in Breast Cancer" @default.
• W2161425022 cites W1888433797 @default.
• W2161425022 cites W1924346446 @default.
• W2161425022 cites W1939003096 @default.
• W2161425022 cites W1966574632 @default.
• W2161425022 cites W1971837077 @default.
• W2161425022 cites W1980131460 @default.
• W2161425022 cites W1994193851 @default.
• W2161425022 cites W1996065081 @default.
• W2161425022 cites W1996283150 @default.
• W2161425022 cites W1999966467 @default.
• W2161425022 cites W2003250674 @default.
• W2161425022 cites W2012072673 @default.
• W2161425022 cites W2013593290 @default.
• W2161425022 cites W2015570563 @default.
• W2161425022 cites W2017631747 @default.
• W2161425022 cites W2025689023 @default.
• W2161425022 cites W2027510392 @default.
• W2161425022 cites W2045260833 @default.
• W2161425022 cites W2052702757 @default.
• W2161425022 cites W2059919519 @default.
• W2161425022 cites W2073363047 @default.
• W2161425022 cites W2084778105 @default.
• W2161425022 cites W2084847779 @default.
• W2161425022 cites W2085529853 @default.
• W2161425022 cites W2096593771 @default.
• W2161425022 cites W2096738564 @default.
• W2161425022 cites W2097407622 @default.
• W2161425022 cites W2099658604 @default.
• W2161425022 cites W2100512801 @default.
• W2161425022 cites W2103563357 @default.
• W2161425022 cites W2103979740 @default.
• W2161425022 cites W2109800555 @default.
• W2161425022 cites W2110444464 @default.
• W2161425022 cites W2114159573 @default.
• W2161425022 cites W2120583908 @default.
• W2161425022 cites W2126275851 @default.
• W2161425022 cites W2131770017 @default.
• W2161425022 cites W2132742086 @default.
• W2161425022 cites W2133243551 @default.
• W2161425022 cites W2135678285 @default.
• W2161425022 cites W2137168156 @default.
• W2161425022 cites W2138361287 @default.
• W2161425022 cites W2140765540 @default.
• W2161425022 cites W2144791212 @default.
• W2161425022 cites W2146478870 @default.
• W2161425022 cites W2149192953 @default.
• W2161425022 cites W2157470118 @default.
• W2161425022 cites W2163017141 @default.
• W2161425022 cites W2165819904 @default.
• W2161425022 cites W2167224460 @default.
• W2161425022 cites W2168893736 @default.
• W2161425022 cites W2285798944 @default.
• W2161425022 cites W4234394290 @default.
• W2161425022 cites W4381243100 @default.
• W2161425022 doi "https://doi.org/10.1634/theoncologist.2011-0115" @default.
• W2161425022 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3233284" @default.
• W2161425022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22016478" @default.
• W2161425022 hasPublicationYear "2011" @default.
• W2161425022 type Work @default.
• W2161425022 sameAs 2161425022 @default.
• W2161425022 citedByCount "52" @default.
• W2161425022 countsByYear W21614250222012 @default.
• W2161425022 countsByYear W21614250222013 @default.
• W2161425022 countsByYear W21614250222014 @default.
• W2161425022 countsByYear W21614250222015 @default.
• W2161425022 countsByYear W21614250222016 @default.
• W2161425022 countsByYear W21614250222018 @default.
• W2161425022 countsByYear W21614250222019 @default.
• W2161425022 countsByYear W21614250222020 @default.
• W2161425022 countsByYear W21614250222022 @default.
• W2161425022 countsByYear W21614250222023 @default.
• W2161425022 crossrefType "journal-article" @default.
• W2161425022 hasAuthorship W2161425022A5015349477 @default.
• W2161425022 hasAuthorship W2161425022A5073714778 @default.
• W2161425022 hasBestOaLocation W21614250221 @default.
• W2161425022 hasConcept C121608353 @default.
• W2161425022 hasConcept C126322002 @default.
• W2161425022 hasConcept C141071460 @default.
• W2161425022 hasConcept C143998085 @default.
• W2161425022 hasConcept C197934379 @default.
• W2161425022 hasConcept C2776999253 @default.
• W2161425022 hasConcept C2777909004 @default.
• W2161425022 hasConcept C2778019345 @default.
• W2161425022 hasConcept C2778375690 @default.
• W2161425022 hasConcept C2778695046 @default.
• W2161425022 hasConcept C526805850 @default.
• W2161425022 hasConcept C530470458 @default.
• W2161425022 hasConcept C71924100 @default.
• W2161425022 hasConceptScore W2161425022C121608353 @default.
• W2161425022 hasConceptScore W2161425022C126322002 @default.
• W2161425022 hasConceptScore W2161425022C141071460 @default.

• next